| human | Q5 |
| P2038 | ResearchGate profile ID | Dan-Cacsire-Castillo-Tong |
| P735 | given name | Dan | Q2487038 |
| Dan | Q2487038 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q36104522 | AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer |
| Q37720579 | Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortium |
| Q40212670 | Association of HER2 codon 655 polymorphism with ovarian cancer |
| Q37176607 | Association of TAP gene polymorphisms and risk of cervical intraepithelial neoplasia |
| Q33689246 | Association of myeloperoxidase with ovarian cancer |
| Q33750749 | Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer |
| Q38774230 | Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OC |
| Q40241512 | HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women |
| Q40390050 | HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women |
| Q34198666 | HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium |
| Q38888628 | Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer |
| Q28275893 | Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium |
| Q38744076 | Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer |
| Q37359509 | Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium |
| Q34135353 | Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data |
| Q40485803 | The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study |
| Q37000854 | Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium |
Search more.